Sharon Benzeno
Chief Commercial Ofc Imm Med · 3 filings · Latest: Jun 26, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | Sharon Benzeno | Chief Commercial Ofc Imm Med | Jun 29, 2026 | Sale | $21.14 | 154,768 | $3.3M | 221,278 | |
ADPT | Sharon Benzeno | Chief Commercial Ofc Imm Med | Jun 29, 2026 | Option Exercise | $7.28 | 103,295 | $751.6K | 376,046 | |
ADPT | Sharon Benzeno | Chief Commercial Ofc Imm Med | Jun 26, 2026 | Sale | $21.00 | 11,034 | $231.7K | 272,751 | |
ADPT | Sharon Benzeno | Chief Commercial Ofc Imm Med | Jun 26, 2026 | Option Exercise | $12.14 | 11,034 | $134.0K | 283,785 | |
ADPT | SHARON BENZENO | — | Jun 29, 2026 | Proposed Sale | $20.96 | 152,931 | $3.2M | — | |
ADPT | SHARON BENZENO | — | Jun 26, 2026 | Proposed Sale | $20.25 | 12,871 | $260.6K | — | |
ADPT | BENZENO SHARON | — | Mar 11, 2026 | Proposed Sale | $14.52 | 63,103 | $916.3K | — | |
ADPT | Sharon Benzeno | Chief Commercial Ofc Imm Med | Mar 11, 2026 | Sale | $13.17 | 63,103 | $831.1K | 272,751 | |
ADPT | SHARON BENZENO | — | Dec 4, 2025 | Proposed Sale | $17.13 | 12,604 | $215.9K | — | |
ADPT | BENZENO SHARON | — | Nov 21, 2025 | Proposed Sale | $16.32 | 308,477 | $5.0M | — | Nov 24 9:58 PM 144/A |
ADPT | SHARON BENZENO | — | Nov 21, 2025 | Proposed Sale | $16.32 | 308,837 | $5.0M | — | |
ADPT | SHARON BENZENO | — | Nov 20, 2025 | Proposed Sale | $15.15 | 201,993 | $3.1M | — | |
ADPT | SHARON BENZENO | — | Nov 19, 2025 | Proposed Sale | $13.75 | 95,932 | $1.3M | — |